Clinical Trial Update: Intratumoral Vaccination With Intuvax Pre-nephrectomy Followed by Sunitinib Post-nephrectomy vs Sunitinib Post-nephrectomy in Newly Diagnosed Metastatic Renal Cell Carcinoma (mRCC) [Phase 2]

View source ↗

Summary

Phase 2 trial comparing intratumoral vaccination with Intuvax followed by sunitinib after nephrectomy versus sunitinib after nephrectomy in newly diagnosed meta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma Metastatic

Drugs mentioned

• Intuvax
• Sunitinib (sunitinib)

Snippet

Sponsor: Mendus | Conditions: Renal Cell Carcinoma, Metastatic | Phase 2 | Status: COMPLETED | Results posted: 2022-08-22